Project Grant R43JG000002
Award Date
9/30/24
Completion Date
3/31/26
Dollars Obligated
$910K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.283
Assistance Type
Project Grant
Place of Performance
United States
Similar Awards
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,857,470 Cooperative Agreement to The Geneva Foundation to develop a multiplex testing platform that can simultaneously detect and identify Plasmodium species infections. This platform will serve as both a diagnostic tool and an epidemiological surveillance tool. The project performance period is from June 1, 2024 to May 31, 2028. Under a $268,312 sub-award, Meso Scale...
This federal Project Grant award of $345,285.00 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The purpose of the award is to develop a higher order multiplex technology called "ZIP-Melt MPT" that can expand the capacity and reduce the cost of digital PCR (dPCR) systems for the quantitative detection and discrimination of gene fusion biomarkers, such as the BCR-ABL1 fusion...
Kepley Biosystems Inc. received a $255,834 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041). The award period runs from May 1, 2021 through December 31, 2021 to support the development of a rapid, sensitive pathogen typing and antibiotic sensitivity test for bloodstream infections, including COVID-19. The Engineering program seeks to improve quality of life and economic strength through...
This Project Grant award from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) provides $1,929,714.00 to Creare LLC, a small business engineering research and development company located in Hanover, New Hampshire. The award will fund the refinement of a very low leakage non-invasive ventilation mask for infectious patients over a 2-year period from September 1, 2024 to August 31, 2026. The CDC program supports a broad range of...
This Project Grant award of $3,055,197.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports the development and evaluation of a rapid, low-cost phenotypic test for the detection of carbapenemase-producing organisms (CPOs). The objective is to create a structurally-programmed sticker microfluidic test that can provide rapid, objective carbapenemase detection and distinguish between carbapenemase...
This $1,373,980 Project Grant award from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) supports the development of "Clinical Ecosystem Surfaces for Improved Disinfection Outcomes and the Prevention of HAI Transmission" by Iasis Molecular Sciences Inc., a for-profit medical technology company based in Spokane, Washington. The 2-year award period runs from September 30, 2024 to September 29, 2026. The project aims to...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Quarksen LLC provides funding to develop an affordable, point-of-care diagnostic device for detecting viral and non-viral sexually transmitted infections (STIs) such as chlamydia, gonorrhea, syphilis, HIV, hepatitis C, and trichomoniasis. The project aims to create a device with an array of sensors that can rapidly and accurately detect STI biomarkers from cervical...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award supports the development of a novel device that can rapidly and automatically extract pathogen DNA from whole blood samples to enable faster diagnosis of sepsis. The $274,858 award to New England Hemolytics, Inc., with a project period from September 1, 2024 to February 28, 2025, will fund the testing and optimization of this technology across common sepsis-causing pathogens. The...
This $402,222 National Science Foundation Project Grant, funded through the Engineering program (CFDA 47.041), supports the development of a new class of simple, inexpensive, portable, and rapid molecular diagnostic platforms. The awardee, University of Cincinnati, will engineer an instrument that can reliably and quickly detect infectious diseases in human samples using a combination of biochemistry, magnetism, fluid physics, and machine learning insights. Specifically, the university will...
This $15,954,880 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) supports the Ministry of Health Central Public Health Laboratories (CPHL) in Uganda to strengthen the country's national health laboratory services and partnerships. The key objectives are to improve the quality of HIV-related testing and other diagnostics through enhanced laboratory coordination and management under the...